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Purpose The aim of this study was to evaluate the validity and reliability of the Seattle Angina 
Questionnaire, Japanese version (SAQ-J) as a disease-specific health outcome scale in patients with coronary
artery disease.
Methods Patients with coronary artery disease were recruited from a university hospital in Tokyo. The
patients completed self-administered questionnaires, and medical information was obtained from the subjects’
medical records. Face validity, concurrent validity evaluated using Short Form 36 (SF-36), known group
differences, internal consistency, and test-retest reliability were statistically analyzed.
Results A total of 354 patients gave informed consent, and 331 of them responded (93.5%). The concurrent
validity was mostly supported by the pattern of association between SAQ-J and SF-36. The patients without
chest symptoms showed significantly higher SAQ-J scores than did the patients with chest symptoms in 
4 domains. Cronbach’s alpha ranged from .51 to .96, meaning that internal consistency was confirmed to a
certain extent. The intraclass correlation coefficient of most domains was higher than the recommended value
of 0.70. The weighted kappa ranged from .24 to .57, and it was greater than .4 for 14 of the 19 items.
Conclusions The SAQ-J could be a valid and reliable disease-specific scale in some part for measuring
health outcomes in patients with coronary artery disease, and requires cautious use. [Asian Nursing
Research 2010;4(2):57–63]
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INTRODUCTION
According to statistics collected by the Ministry of
Health, Labour and Welfare, approximately 900,000
people have been diagnosed with coronary artery dis-
ease (CAD); CAD accounts for over half of cardio-
vascular disease making it the second leading cause of
death in Japan (Japan Ministry of Health, Labour, and
Welfare,2005).Therefore, strategies for the administra-
tion of efficient treatment and secondary prevention
of this disease merit extensive investigation.Addition-
ally, it is important to evaluate the health outcomes, in-
cluding the health-related quality of life, as well as the
mortality and physiologic measures in CAD patients.
When assessing health outcomes in CAD patients,
a disease-specific scale is preferred to a generic one for
the evaluation of the general condition of the patients
and the response to treatment (Ikegami, Fukuhara,
Shimotsuma, & Ikeda, 2001). The Seattle Angina
Questionnaire (SAQ) is a disease-specific health out-
come scale developed in 1995 to assess the health out-
comes of CAD patients (Spertus et al., 1995). It has
been used in many previous studies (Chen, Daley, &
Thibault, 1996; Graham et al., 2006; Spertus et al.,
2006; Weintraub et al., 2008). While the SAQ has
been translated into Japanese by Cardiovascular Out-
comes Incorporated (USA), the validity and reliability
of the Japanese version have not been psychometrically
tested.To confirm the SAQ is an accurate, stable, valid
and reliable scale in measuring the health outcomes in
Japan, its accuracy, stability, validity and reliability have
to be tested before use.The present study aims to eval-
uate the validity and reliability of the Japanese version
of the SAQ (SAQ-J) in Japanese patients with CAD.
METHODS
The present study was a cross-sectional, mail-based
psychometric survey. It was approved by the univer-
sity institutional review board.
Pilot study for face validity
In June 2007, SAQ-J was administered to 8 patients,
who were regularly followed up at a university hospital
in Tokyo. The time taken to complete the question-
naire was approximately 5 minutes, and no confusing
or unclear items were reported by the patients.
Data collection
From July 2007 to March 2008, patients were re-
cruited from the inpatient ward and outpatient de-
partment at a university hospital in Tokyo. Patients
were eligible for participating in this study if they
had been diagnosed with CAD, were aged 20 years
or older, were able to read and write in Japanese,
and did not have impaired cognitive function.
In the outpatient setting, the study procedure was
explained to patients who met the eligibility criteria.
Patients then signed the consent forms in a private
room. Next, they were given the first questionnaires
including SAQ-J, Short Form 36 (SF-36) and details
regarding items such as marital status, education,
employment, living status and history of smoking;
they were asked to fill out the questionnaires at home
and send them back by post.The patients who failed
to respond by 2 weeks were sent reminders. In the
hospital setting, the questionnaires were given after
obtaining informed consent in a private room and
collected within a few days.
Two weeks after the first survey was completed,
the second SAQ-J was mailed or handed to the pa-
tients who had responded to the first sets of measures
and who had agreed to have the SAQ-J administered
twice.This was done for the evaluation of test-retest
reliability. The time interval for this assessment was
from 2 to 3 weeks in this study.
Relevant medical information regarding specifi-
cations such as history of myocardial infarction, per-
cutaneous coronary intervention, and coronary artery
baypass grafting (CABG), number of affected vessels,
left ventricular ejection fraction, comorbidities, and
disease duration was obtained from the patients’
medical records.
Self-administered health outcome scales
The SAQ is a 19-item self-administered questionnaire
and consists of 5 domains: physical limitation (9
items), anginal stability (1 item), anginal frequency
(2 items), treatment satisfaction (4 items) and quality
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of life (3 items). Each item is answered using 5- or
6-point Likert scales (Spertus et al., 1995). The score
for a particular domain was calculated by adding the
item scores for that domain; the domain scores were
converted to a 0–100 scale, with 100 representing
the best outcome (Spertus et al.).
The Short Form 36 version 2 Japanese (SF-36),
which was used for assessing the concurrent validity
of the SAQ-J, is a generic health outcome scale con-
sisted of 36 items covering eight domains: physical
functioning, physical role, bodily pain, general health,
vitality, social functioning, emotional role and mental
health (Fukuhara & Suzukamo, 1994). The physical
component summary and the mental component
summary scores were computed from the scores of
these eight domains (Fukuhara & Suzukamo). How-
ever, the usage of summary scores of SF-36 Japanese
is not recommended due to the difference in domain
structure between the Japanese version and the orig-
inal version. Thus, these summary scores are not
shown in the present study.
Statistical analyses
Patient characteristics and each domain score of the
SAQ-J were evaluated by descriptive analysis; floor
and ceiling effects were determined.
To assess the concurrent validity of the SAQ-J,
Pearson’s product moment correlation coefficient
between the scores of the SAQ-J and SF-36 was
computed. As known group differences, the SAQ-J
scores of patients with and without chest symptoms
were evaluated with the Mann-Whitney U test.
Internal consistency was assessed by computing
Cronbach’s alpha.Test-retest reliability was assessed by
computing the intraclass correlation coefficient of each
domain and the weighted kappa value of each item.
Statistical analyses were performed using SPSS ver-
sion 14.0 (SPSS Inc., Chicago, IL, USA) for Windows.
RESULTS
Data collection
A total of 356 patients were eligible to participate
in this study; 354 gave informed consent, and 335
responded.After excluding 4 patients who had miss-
ing items on more than 90% of the questionnaires,
the final number of candidates who participated in
the first study was 331 (93.5%).
A total of 253 patients signed the consent form
to participate in the second study for the assessment
of test-retest reliability. The second SAQ-J ques-
tionnaires were sent to 230 of the 253 patients who
responded to the first study, and 202 (86.0%)
patients completed the questionnaires.
Patient characteristics
Table 1 shows the characteristics of the study partic-
ipants: 262 (78.4%) patients were male, the mean age
was 68.1 ± 10.4 years, and 23.9% were inpatients.
Floor and ceiling effects and domain scores of 
the SAQ-J
The floor and ceiling effects and domain scores of the
SAQ-J are shown in Table 2. Many patients showed
a ceiling effect in the case of the anginal frequency
domain.
Validity of the SAQ-J
Table 3 shows the correlation between SAQ-J and
SF-36, which was used to assess concurrent validity.
The physical limitation domain of the SAQ-J was
more strongly correlated with Physical Functioning
and Role Functioning than with the other domains of
the SF-36. Anginal frequency was more closely cor-
related with Physical Functioning and Bodily Pain
than with the other domains.The treatment satisfac-
tion and quality of life domains of the SAQ-J were
highly correlated with General Health, Vitality and
Mental Health. With regard to the known group
differences, shown in Table 4, the patients without
chest symptoms exhibited significantly higher SAQ-J
scores than those who had poor scores for the phys-
ical limitation, anginal frequency and quality of life
domains.
Reliability of the SAQ-J
Table 5 shows the internal consistency and the test-
retest reliability of the SAQ-J. In the case of the phys-
ical limitation and treatment satisfaction domains,
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Table 1
Medical and Demographic Characteristics
Characteristics (n) n %a
Gender (331)
Male 262 78.4
Employment status (323)
Employed 156 48.3
Living alone (326) 41 12.6
Marital status (322)
Single 25 7.8
Married 246 76.4
Divorced 18 5.6
Widowed 33 10.2
Educational background (321)
Middle high school 54 16.8
High school 127 39.6
Community college 29 9.0
College 111 34.6
Smoking status (322)
Current 41 12.7
Past 183 56.8
Never 98 30.4
Previous myocardial infarction (324) 108 33.4
Previous PCI (324) 170 52.5
Previous CABG (324) 144 44.4
Hyperlipidemia (324) 208 64.2
Hypertension (323) 234 72.4
Diabetes (324) 167 51.5
Number of diseased coronary 
vesselsb (324)
1 68 21.0
2 88 27.2
3 132 40.7
Left main trunk lesionb (323) 43 13.3
Medication (324)
Nitrate 140 43.2
β-Blocker 138 42.6
Calcium antagonist 160 49.4
Statin 193 59.6
Antiplatelet 292 90.1
ACE inhibitor 180 55.5
(Contd)
Patient status (331)
Inpatient 79 23.9
M ± SD
Age (331) 68.1 ± 10.4
Disease duration (320; yr) 5.7 ± 7.5
Body mass index (326) 23.7 ± 4.1
Left ventricular ejection 60.0 ± 12.4
fraction (317; %)
Note. PCI = Percutaneous coronary intervention; CABG = Coro-
nary artery bypass graft; ACE = angiotensin-coverting enzyme.
aPercentages do not add up to 100% due to rounding; bover 75%
of stenosis in the vessels.
Cronbach’s alpha exceeded .7. The intraclass corre-
lation coefficient of all domains, except for the
anginal frequency domain, was .70. The weighted
kappa was .24–.57.
DISCUSSION
Measuring health outcomes with the SAQ-J would
be a substantial achievement and would be of consid-
erable importance in the clinical and research settings
since very few CAD-specific scales are currently
applicable to the Japanese population.
Regarding the face validity of the SAQ-J, it was
pilot-tested before proceeding to the major field
study, and none of the item was reported as confus-
ing or unclear. Consequently, the face validity of
SAQ-J was confirmed.
As mentioned above, the ceiling effect of the
SAQ-J was observed in many patients. It was be-
cause the majority of the participants in the present
study were recruited from an outpatient depart-
ment and were not severely ill. This was probably
associated with better outcomes.
As predicted, the concurrent validity was largely
supported by the pattern of association between
SF-36 and SAQ-J (Garratt, Hutchinson, & Russell,
2001; Hofer, Benzer, Schussler, von Steinbuchel, &
Oldridge, 2003; Pettersen, Reikvam, & Stavem,
2005; Spertus et al., 1995). The physical limitation,
treatment satisfaction, and quality of life domains
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Table 2
Floor and Ceiling Effects, Domain Scores, and Internal Consistency of the Seattle Angina 
Questionnaire-Japanese Version (SAQ-J)
SAQ-J (n) Floora % Ceilingb % Domain score M ± SD Cronbach’s alpha
Physical limitation (307) 0.7 16.9 74.8 ± 22.0 .96
Anginal stability (312) 2.2 8.0 52.2 ± 17.1 N/A
Anginal frequency (324) 0.0 73.1 93.5 ± 13.6 .51
Treatment satisfaction (319) 0.3 26.6 83.3 ± 15.1 .78
Quality of life (320) 0.6 10.0 71.9 ± 20.1 .67
Note. N/A = not applicable. aLowest scale score; bhighest scale score.
Table 3
Concurrent Validity of the Seattle Angina Questionnaire-Japanese Version (SAQ-J)
SF-36
SAQ-J (n)
PF RF BP GH VT SF RE MH PCS MCS
Physical limitation (307) .78a* .66a* .43a* .37a* .51a* .52* .58* .33* .76a* .34*
Anginal stability (312) .06 –.02 .04 .04 .10 .03 –.03 .08 .04 .04
Anginal frequency (324) .36a* .26* .38a* .23a* .29a* .21* .29* .30* .37a* .22*
Treatment satisfaction (319) .19* .23* .20a* .30a* .36a* .28* .31* .33a* .21* .37*
Quality of life (320) .33* .42* .34a* .42a* .42a* .41* .47* .43a* .39a* .46*
Note. SF-36 = Short Form-36; PF = physical functioning; RF = role functioning–physical; BP = bodily pain; GH = general health;
VT = vitality; SF = social functioning; RE = role functioning–emotional; MH = mental health; PCS = physical component summary;
MCS = mental component summary. aPredited substantial associations. Pearson’s product-moment correlation coefficient: *p < .01.
Table 4
Known-Group Differences of the Seattle Angina Questionnaire-Japanese Version (SAQ-J)
Symptomatic (n = 60) Asymptomatic (n = 263)
Domain score
M ± SD M ± SD
p
SAQ-J
Physical limitation 58.8 ± 24.6 73.8 ± 20.9 < .001
Anginal stability 50.9 ± 29.1 52.8 ± 13.4 .27
Anginal frequency 75.0 ± 19.7 97.5 ± 7.6 < .001
Treatment satisfaction 75.4 ± 18.3 85.0 ± 13.8 < .001
Quality of life 53.5 ± 22.8 75.8 ± 18.4 < .001
of the SAQ-J were moderately correlated with Role
Functioning-Emotional than with other domains,
which were expected to have higher correlation.
Other because the generic SF-36 scale was used;
however, the results were equivalent to those ob-
tained with other versions of the SAQ.
Known-group differences of the SAQ-J were ver-
ified. Because the patients’ medical records did not
include data regarding the division of patients accord-
ing to the Canadian Cardiovascular Society Classifi-
cation and because most patients in this study had
relatively good cardiac function, data from patients
Validity and Reliability of SAQ-J in Patients
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with or without chest symptoms were used. In previ-
ous studies, patients with chest symptoms showed
lower health outcome scores than those without
chest symptoms (Nishiyama et al., 2005).As hypoth-
esized, asymptomatic patients showed higher SAQ-J
scores than the symptomatic patients who had poor
scores for all domains, except the anginal stability do-
main. The anginal stability domain included a ques-
tion about chest symptoms present 1 month before
the survey and the control of these symptoms.
Cronbach’s alpha was used to assess internal con-
sistency, which was confirmed to a certain extent.
The physical limitation and treatment satisfaction
domain scores exceeded .7—the suggested value
that indicates scale validity (Fayers & Machin, 2007).
The alpha values for the anginal frequency and qual-
ity of life domains were lower than the recommended
values; however, the alpha for the quality of life
domain (.67) was acceptable.
The test-retest reliability of the SAQ-J was con-
firmed. The intraclass correlation coefficients of the
scores of all domains of the SAQ-J, except for the
anginal stability domain, exceeded the recommended
value of .7 (Fayers & Machin, 2007). Compared to
the original version, the Japanese version had better
results with regard to the score for the anginal stability
domain, despite the score not being greater than .7.
Even though SAQ-J has anginal stability and angi-
nal frequency domains that might be changed over
time, we tested the test-retest reliability following
the validation study of the original version. The
weighted kappa exceeded the recommended value
of .4 for 14 of the 19 items (Fayers & Machin). The
five items for which the weighted kappa was below
.4 showed a high rate of concordance.
The generalizability of the findings of the present
study is limited because of geographical limitations
and disease severity. Further evaluation of the SAQ-J
should be performed in community hospitals and
should include severely ill patients.
CONCLUSION
The present study evaluated the validity and relia-
bility of the SAQ-J, a disease-specific health outcome
scale in Japanese patients with CAD. The validity
and reliability of this scale were verified through a
patient-based field study. The SAQ-J was found to
be a valid and reliable scale in CAD patients in some
part; therefore, it requires cautious use. Studies that
focus on other samples are expected for the future
studies.
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